PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer have?
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer has 154 citations in the OpenAlex counts ScholarIQ stores.
When was PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer published?
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer has 2018 year in the ScholarIQ index.
What is the open-access status of PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer has gold oa status in the ScholarIQ index.
What is the DOI of PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?
The DOI for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is on the source record.
What is the PMID of PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?
The PMID for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is on the source record.
What is the OpenAlex record for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer?
The OpenAlex for PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer is on the source record.